Physician profile
Amanda B Treon
NPI 1437349610
$547.36
in general payments reported to CMS, 2019-2025
12 companies · $27.50 in 2025
The $27.50 reported for 2025 was less than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $327 · 2022: $53.75 · 2023: $13.06 · 2024: $126 · 2025: $27.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $166.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $261.40 | 2021-2025 | |
| Exeltis, USA INC. | $61.40 | 2021 | |
| Avion Pharmaceuticals | $37.63 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $35.39 | 2021 | |
| Hologic Sales and Service, LLC | $28.18 | 2022 | |
| Therapeuticsmd, INC. | $26.96 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.94 | 2021-2022 | |
| Gynesonics, INC. | $17.80 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mylan Pharmaceuticals INC. | $14.58 | 2021 | |
| Novo Nordisk INC | $13.52 | 2022 | |
| Minerva Surgical, INC | $13.06 | 2023 | |
| Acella Pharmaceuticals, LLC | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Treon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.